Literature DB >> 25593329

Coagulation takes center stage in inflammation.

Katerina Akassoglou1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25593329      PMCID： PMC4296004          DOI： 10.1182/blood-2014-11-609222

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

Review 2.  Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.

Authors:  Berthold Hoppe; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

3.  Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.

Authors:  Harini Raghu; Carolina Cruz; Cheryl L Rewerts; Malinda D Frederick; Sherry Thornton; Eric S Mullins; Jonathan G Schoenecker; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

4.  The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A.

Authors:  Matthew J Flick; Anil K Chauhan; Malinda Frederick; Kathryn E Talmage; Keith W Kombrinck; Whitney Miller; Eric S Mullins; Joseph S Palumbo; Xunzhen Zheng; Naomi L Esmon; Charles T Esmon; Sherry Thornton; Ann Becker; Leslie A Pelc; Enrico Di Cera; Denisa D Wagner; Jay L Degen
Journal:  Blood       Date:  2011-03-24       Impact factor: 22.113

5.  Exacerbation of antigen-induced arthritis in urokinase-deficient mice.

Authors:  N Busso; V Péclat; K Van Ness; E Kolodziesczyk; J Degen; T Bugge; A So
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

6.  Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.

Authors:  Matthew J Flick; Christine M LaJeunesse; Kathryn E Talmage; David P Witte; Joseph S Palumbo; Malinda D Pinkerton; Sherry Thornton; Jay L Degen
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease.

Authors:  Ryan A Adams; Jan Bauer; Matthew J Flick; Shoana L Sikorski; Tal Nuriel; Hans Lassmann; Jay L Degen; Katerina Akassoglou
Journal:  J Exp Med       Date:  2007-03-05       Impact factor: 14.307

8.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.

Authors:  Dimitrios Davalos; Jae Kyu Ryu; Mario Merlini; Kim M Baeten; Natacha Le Moan; Mark A Petersen; Thomas J Deerinck; Dimitri S Smirnoff; Catherine Bedard; Hiroyuki Hakozaki; Sara Gonias Murray; Jennie B Ling; Hans Lassmann; Jay L Degen; Mark H Ellisman; Katerina Akassoglou
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919
  8 in total
  7 in total

1.  Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation.

Authors:  Jae Kyu Ryu; Mark A Petersen; Sara G Murray; Kim M Baeten; Anke Meyer-Franke; Justin P Chan; Eirini Vagena; Catherine Bedard; Michael R Machado; Pamela E Rios Coronado; Thomas Prod'homme; Israel F Charo; Hans Lassmann; Jay L Degen; Scott S Zamvil; Katerina Akassoglou
Journal:  Nat Commun       Date:  2015-09-10       Impact factor: 14.919

Review 2.  Emerging Role of Immunity in Cerebral Small Vessel Disease.

Authors:  Ying Fu; Yaping Yan
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

3.  Can Aspirin Minimize Stroke Risk and New Lesion Formation in Multiple Sclerosis?

Authors:  Jagannadha Avasarala; Naveen Parti
Journal:  Front Neurol       Date:  2018-08-08       Impact factor: 4.003

4.  Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19.

Authors:  Galit H Frydman; Edward W Boyer; Rosalynn M Nazarian; Elizabeth M Van Cott; Gregory Piazza
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 5.  Regenerative Medicine for Equine Musculoskeletal Diseases.

Authors:  Iris Ribitsch; Gil Lola Oreff; Florien Jenner
Journal:  Animals (Basel)       Date:  2021-01-19       Impact factor: 2.752

Review 6.  Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface.

Authors:  Sophia Bardehle; Victoria A Rafalski; Katerina Akassoglou
Journal:  Front Cell Neurosci       Date:  2015-09-16       Impact factor: 5.505

7.  Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).

Authors:  Emily A Larson; Hillary J Larson; Jason A Taylor; Robert F Klein
Journal:  Calcif Tissue Int       Date:  2021-06-12       Impact factor: 4.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.